Showing results (751-760 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|July 27, 2017
Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicityMarta Pellicer, Xandra García-González, María I García, et al.
Pharmacogenomics|March 30, 2016
Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson's diseaseVivian Altmann, Artur F Schumacher-Schuh, Mariana Rieck, et al.
Pharmacogenomics|March 30, 2016
Pyrexia in dabrafenib-treated melanoma patients is not associated with common genetic variation or HLA polymorphismsDiptee Kulkarni, Kijoung Song, Linda Briley, et al.
Pharmacogenomics|February 20, 2016
A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantationLucie Pouché, Matthias Koitka, Jana Stojanova, et al.
Pharmacogenomics|February 20, 2016
Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistanceOliver Bruhn, Katharina Drerup, Meike Kaehler, et al.
Pharmacogenomics|December 15, 2015
Survivin polymorphism is associated with disease activity in rheumatoid arthritis patientsBarbara Jenko, Sonja Praprotnik, Saša Čučnik, et al.
Pharmacogenomics|December 15, 2015
Functional characterization of CYP2D6 novel allelic variants identified in the Chinese Han populationQingqing Xu, Zhenqiang Wu, Lun Yang, et al.
Pharmacogenomics|December 15, 2015
Rapid and reliable genotyping of HLA-B*58:01 in four Chinese populations using a single-tube duplex real-time PCR assayXing Kang, Rong Chen, Min Han, et al.
Pharmacogenomics|October 25, 2017
Pharmacogenetics of trazodone in healthy volunteers: association with pharmacokinetics, pharmacodynamics and safetyMiriam Saiz-Rodríguez, Carmen Belmonte, Nieves Derqui-Fernández, et al.
Pharmacogenomics|October 25, 2017
OCT1 pharmacogenetics in pain management: is a clinical application within reach?Mladen V Tzvetkov
Pageof 276